@article{castera_nejm,
  author       = {Castera, Laurent and Rinella, Mary E. and Tsochatzis, Emmanuel A.},
  title        = {Noninvasive Assessment of Liver Fibrosis},
  journal      = {New England Journal of Medicine},
  shortjournal = {N Engl J Med},
  year         = {2025},
  volume       = {393},
  number       = {17},
  pages        = {1715-1729},
  doi          = {10.1056/NEJMra2403308},
  url          = {https://www.nejm.org/doi/full/10.1056/NEJMra2403308}
}

@article{easl_easd_easo_2024,
  author       = {{European Association for the Study of the Liver} and
                  {European Association for the Study of Diabetes} and
                  {European Association for the Study of Obesity}},
  title        = {EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)},
  journal      = {Journal of Hepatology},
  shortjournal = {J Hepatol},
  year         = {2024},
  volume       = {81},
  number       = {3},
  pages        = {492-542},
  doi          = {10.1016/j.jhep.2024.04.031},
  url          = {https://www.journal-of-hepatology.eu/article/S0168-8278(24)00329-5/pdf}
}

@article{RN565,
  author       = {Targher, Giovanni and Valenti, Luca and Byrne, Christopher D.},
  title        = {Metabolic Dysfunction–Associated Steatotic Liver Disease},
  journal      = {New England Journal of Medicine},
  shortjournal = {N Engl J Med},
  year         = {2025},
  volume       = {393},
  number       = {7},
  pages        = {683-698},
  doi          = {10.1056/NEJMra2412865},
  url          = {https://www.nejm.org/doi/full/10.1056/NEJMra2412865}
}

@online{SPF2021Diabete,
  author       = {{Santé publique France}},
  title        = {Le diabète en France : les chiffres 2020},
  year         = {2021},
  date         = {2021-11-10},
  url          = {https://www.santepubliquefrance.fr/les-actualites/2021/le-diabete-en-france-les-chiffres-2020},
  urldate      = {2025-11-22},
  institution  = {Santé publique France},
  langid       = {french}
}

@article{EASL_DecompCirrhosis_2018,
  author  = {{European Association for the Study of the Liver}},
  title   = {EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis},
  journal = {Journal of Hepatology},
  shortjournal = {J Hepatol},
  year    = {2018},
  volume  = {69},
  number  = {2},
  pages   = {406--460},
  doi     = {10.1016/j.jhep.2018.03.024}
}

@article{Gines_LancetCirrhosis_2021,
  author  = {Gin{\`e}s, Pere and Krag, Aleksander and Abraldes, Juan G and Sol{\`a}, Elsa and Fabrellas, Noem{\'i} and Betrosian, Alexios},
  title   = {Liver cirrhosis},
  journal = {The Lancet},
  shortjournal = {Lancet},
  year    = {2021},
  volume  = {398},
  number  = {10308},
  pages   = {1359--1376},
  doi     = {10.1016/S0140-6736(21)01374-X}
}

@article{Moreau_CANONIC_2013,
  author  = {Moreau, Richard and Jalan, Rajiv and Gines, Pere and et al.},
  title   = {Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis},
  journal = {Journal of Hepatology},
  shortjournal = {J Hepatol},
  year    = {2013},
  volume  = {59},
  number  = {3},
  pages   = {834--844},
  doi     = {10.1016/j.jhep.2013.06.012}
}

@article{Moga_AKIFrance_2022,
  author  = {Moga, Liliana and Robic, Marie-Agn{\`e}s and Blasco-Perrin, H{\'e}l{\`e}ne et al.},
  title   = {Acute kidney injury in patients with cirrhosis: epidemiology and outcomes in a French multicentre cohort},
  journal = {Clinical Research in Hepatology and Gastroenterology},
  shortjournal = {Clin Res Hepatol Gastroenterol},
  year    = {2022},
  volume  = {46},
  pages   = {101822},
  doi     = {10.1016/j.clinre.2022.101822}
}

@article{Sort_SBPAlbumin_1999,
  author  = {Sort, Pau and Navasa, Miquel and Arroyo, Vicente and et al.},
  title   = {Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis},
  journal = {New England Journal of Medicine},
  shortjournal = {N Engl J Med},
  year    = {1999},
  volume  = {341},
  number  = {6},
  pages   = {403--409},
  doi     = {10.1056/NEJM199908053410603}
}

@article{Caraceni_ANSWER_2018,
  author  = {Caraceni, Paolo and Riggio, Oliviero and Angeli, Paolo and et al.},
  title   = {Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial},
  journal = {The Lancet},
  shortjournal = {Lancet},
  year    = {2018},
  volume  = {391},
  number  = {10138},
  pages   = {2417--2429},
  doi     = {10.1016/S0140-6736(18)30840-7}
}

@article{Sola_MACHT_2018,
  author  = {Sol{\`a}, Elsa and Sole, Concepci{\'o}n and Sim{\'o}, Rafael and et al.},
  title   = {Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation (MACHT): a randomized, double-blind, placebo-controlled trial},
  journal = {Journal of Hepatology},
  shortjournal = {J Hepatol},
  year    = {2018},
  volume  = {69},
  number  = {6},
  pages   = {1250--1259},
  doi     = {10.1016/j.jhep.2018.08.006}
}

@article{China_ATTIRE_2021,
  author  = {China, Laurence and Freemantle, Nick and Forrest, Elizabeth and et al.},
  title   = {A randomized trial of albumin infusions in hospitalized patients with cirrhosis},
  journal = {New England Journal of Medicine},
  shortjournal = {N Engl J Med},
  year    = {2021},
  volume  = {384},
  number  = {9},
  pages   = {808--817},
  doi     = {10.1056/NEJMoa2022166}
}

@article{AASLD_PalliativeCirrhosis_2022,
  author  = {Rogal, Shari S. and Umehnilo, Chinenye and Lamba, Sangeeta et al.},
  title   = {AASLD practice guidance: Palliative care and symptom-based management in decompensated cirrhosis},
  journal = {Hepatology},
  shortjournal = {Hepatology},
  year    = {2022},
  volume  = {76},
  number  = {5},
  pages   = {1489--1513},
  doi     = {10.1002/hep.32665}
}

@article{FrenchHepaticFailure_2020,
  author       = {Ganne-Carrié, Nathalie and Nahon, Pierre and Layese, Régine et al.},
  title        = {Causes and Trends of Liver-Related Hospitalizations in France: A Nationwide Study Using PMSI Data},
  journal      = {JHEP Reports},
  shortjournal = {JHEP Rep},
  year         = {2020},
  volume       = {2},
  number       = {6},
  pages        = {100162},
  doi          = {10.1016/j.jhepr.2020.100162}
}

@article{Tantai_Sarcopenia_2022,
  author  = {Tantai, X. and Liu, Y. and Yeo, Y.-H. and et al.},
  title   = {Sarcopenia in Patients with Cirrhosis: A Systematic Review and Meta-analysis},
  journal = {Clinical Nutrition},
  year    = {2022},
  volume  = {41},
  number  = {5},
  pages   = {1012--1024},
  doi     = {10.1016/j.clnu.2022.02.014},
  shortjournal = {Clin Nutr}
}

@article{Plauth_ESPEN_2019,
  author = {Plauth, Michael and Bernal, Willy and Dasarathy, Srinivasan and et al.},
  title  = {ESPEN guideline on clinical nutrition in liver disease},
  journal = {Clinical Nutrition},
  year    = {2019},
  volume  = {38},
  number  = {2},
  pages   = {485--521},
  doi     = {10.1016/j.clnu.2018.12.022},
  shortjournal = {Clin Nutr}
}

@article{Tsien_LateEveningSnack_2012,
  author = {Tsien, Cindy and Garber, Arnold and Narayanan, Sadagopan and et al.},
  title  = {Late evening snack improves survival in cirrhosis: a randomized clinical trial},
  journal = {Hepatology},
  year    = {2012},
  volume  = {56},
  number  = {1},
  pages   = {68--76},
  doi     = {10.1002/hep.25638},
  shortjournal = {Hepatology}
}

@article{Loomba_AlcoholAbstinence_2020,
  author = {Loomba, Rohit and Friedman, Scott and Shibata, Demetrius},
  title  = {Impact of alcohol abstinence on fibrosis regression in chronic liver disease},
  journal = {Journal of Hepatology},
  year    = {2020},
  volume  = {72},
  number  = {3},
  pages   = {441--450},
  doi     = {10.1016/j.jhep.2019.10.017},
  shortjournal = {J Hepatol}
}

@article{Addolorato_AlcoholCirrhosis_2016,
  author = {Addolorato, Giovanni and Mirijello, Antonio and Leggio, Lorenzo et al.},
  title  = {Alcohol abstinence in alcoholic cirrhosis: survival and disease course},
  journal = {Alcohol and Alcoholism},
  year    = {2016},
  volume  = {51},
  number  = {3},
  pages   = {284--291},
  doi     = {10.1093/alcalc/agv093},
  shortjournal = {Alcohol Alcohol}
}

@article{Addolorato_Baclofen_2007,
  author = {Addolorato, Giovanni and Leggio, Lorenzo and Ferrulli, Anna and et al.},
  title  = {Baclofen efficacy in maintaining abstinence in alcoholic cirrhosis: a randomized trial},
  journal = {The Lancet},
  year    = {2007},
  volume  = {370},
  number  = {9603},
  pages   = {1915--1922},
  doi     = {10.1016/S0140-6736(07)61814-5},
  shortjournal = {Lancet}
}

@article{Ng2017,
  author    = {Ng, Siew C and Shi, Hyun-Ho and Hamidi, Nayim and et al.},
  title     = {Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies},
  journal   = {Lancet},
  journal-abbrev = {Lancet},
  year      = {2017},
  volume    = {390},
  number    = {10114},
  pages     = {2769--2778},
  doi       = {10.1016/S0140-6736(17)32448-0},
  pmid      = {29050646},
  url       = {https://pubmed.ncbi.nlm.nih.gov/29050646/}
}

@article{EASL2024MASLD,
  author    = {{EASL Clinical Practice Guidelines Committee}},
  title     = {EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis—2024 update (MASLD/MASH)},
  journal   = {J Hepatol},
  journal-abbrev = {J Hepatol},
  year      = {2024},
  doi       = {10.1016/j.jhep.2024.04.003},
  url       = {https://www.journal-of-hepatology.eu/article/S0168-8278(24)00123-4/fulltext}
}

@article{ECCO2023,
  author    = {Magro, Fernando and Bossuyt, Peter and Allez, Matthieu and et al.},
  title     = {ECCO Guidelines on Therapeutics in Crohn’s Disease: 2023 Update},
  journal   = {J Crohns Colitis},
  journal-abbrev = {J Crohns Colitis},
  year      = {2023},
  volume    = {17},
  number    = {2},
  pages     = {183--208},
  doi       = {10.1093/ecco-jcc/jjac171},
  pmid      = {36548240},
  url       = {https://pubmed.ncbi.nlm.nih.gov/36548240/}
}

@misc{DREES2021,
  author       = {{DREES}},
  title        = {Les établissements de santé en 2021},
  year         = {2023},
  howpublished = {Études et Résultats, DREES},
  url          = {https://drees.solidarites-sante.gouv.fr/publications/les-etablissements-de-sante-en-2021}
}

@misc{SNDS_MICI2022,
  author       = {{Caisse Nationale d'Assurance Maladie}},
  title        = {Analyse nationale du parcours des patients atteints de MICI en France},
  year         = {2022},
  howpublished = {Rapport SNDS},
  url          = {https://assurance-maladie.ameli.fr}
}

@misc{APHP2023Plan,
  author       = {{AP-HP}},
  title        = {Plan stratégique médical 2023–2028},
  year         = {2023},
  howpublished = {Document institutionnel AP--HP},
  url          = {https://www.aphp.fr}
}

@misc{CollegialeHGE2023,
  author       = {{Collégiale d’Hépato-Gastroentérologie AP--HP}},
  title        = {Projet médical 2023--2028 de la Collégiale HGE},
  year         = {2023},
  howpublished = {Document institutionnel AP--HP},
  url          = {https://www.aphp.fr}
}



@article{Ng_LancetGlobalIBD_2017,
  author       = {Ng, Siew C and Shi, Hyun-Ho and Hamidi, Nayim and et al.},
  title        = {Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies},
  journal      = {Lancet},
  journal-abbrev = {Lancet},
  year         = {2017},
  volume       = {390},
  number       = {10114},
  pages        = {2769--2778},
  doi          = {10.1016/S0140-6736(17)32448-0},
  pmid         = {29050646},
  url          = {https://pubmed.ncbi.nlm.nih.gov/29050646/}
}

@article{Richard_EpidemioPresseMed_2025,
  author       = {Richard, Mathilde and Bourrier, Antoine and Beaugerie, Laurent},
  title        = {Épidémiologie des maladies inflammatoires chroniques de l’intestin en France: actualisation 2025},
  journal      = {Presse Med},
  journal-abbrev = {Presse Med},
  year         = {2025},
  volume       = {54},
  number       = {2},
  pages        = {104--118},
  doi          = {10.1016/j.lpm.2024.105241}
}

@article{ECCO_2023_Crohn,
  author       = {Magro, Fernando and Bossuyt, Peter and Allez, Matthieu and et al.},
  title        = {ECCO Guidelines on Therapeutics in Crohn’s Disease: 2023 Update},
  journal      = {J Crohns Colitis},
  journal-abbrev = {J Crohns Colitis},
  year         = {2023},
  volume       = {17},
  number       = {2},
  pages        = {183--208},
  doi          = {10.1093/ecco-jcc/jjac171},
  pmid         = {36548240},
  url          = {https://pubmed.ncbi.nlm.nih.gov/36548240/}
}

@article{STRIDE2_2021,
  author       = {Turner, Dan and Ricciuto, Anthony and Lewis, Jessica D and et al.},
  title        = {STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative of the International Organization for the Study of IBD (IOIBD)},
  journal      = {Gastroenterology},
  journal-abbrev = {Gastroenterology},
  year         = {2021},
  volume       = {160},
  number       = {5},
  pages        = {1570--1583},
  doi          = {10.1053/j.gastro.2020.12.031},
  pmid         = {33359090},
  url          = {https://pubmed.ncbi.nlm.nih.gov/33359090/}
}

@article{FerInjectable_IBD_Anemia_2015,
  author       = {Dignass, Axel and Gasche, Christoph and Bettenworth, Dominik and et al.},
  title        = {European consensus on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases},
  journal      = {J Crohns Colitis},
  journal-abbrev = {J Crohns Colitis},
  year         = {2015},
  volume       = {9},
  number       = {3},
  pages        = {211--222},
  doi          = {10.1093/ecco-jcc/jju009},
  pmid         = {25518052},
  url          = {https://pubmed.ncbi.nlm.nih.gov/25518052/}
}

@article{IBD_MentalHealth_2021,
  author       = {Zhang, Feng and Li, Ying and Na, Yan and et al.},
  title        = {Mental health in inflammatory bowel disease: A systematic review and meta-analysis},
  journal      = {J Psychosom Res},
  journal-abbrev = {J Psychosom Res},
  year         = {2021},
  volume       = {147},
  pages        = {110541},
  doi          = {10.1016/j.jpsychores.2021.110541},
  pmid         = {33453552},
  url          = {https://pubmed.ncbi.nlm.nih.gov/33453552/}
}

@misc{SNDS_MICI2022,
  author       = {{Caisse Nationale d'Assurance Maladie}},
  title        = {Analyse nationale du parcours des patients atteints de MICI en France},
  howpublished = {Rapport SNDS},
  year         = {2022},
  url          = {https://assurance-maladie.ameli.fr}
}

@article{STRIDE2_2021,
  author       = {Turner, Dan and Ricciuto, Anthony and Lewis, Jessica D and et al.},
  title        = {STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative of the International Organization for the Study of IBD (IOIBD)},
  journal      = {Gastroenterology},
  journal-abbrev = {Gastroenterology},
  year         = {2021},
  volume       = {160},
  number       = {5},
  pages        = {1570--1583},
  doi          = {10.1053/j.gastro.2020.12.031},
  pmid         = {33359090},
  url          = {https://pubmed.ncbi.nlm.nih.gov/33359090/}
}

@misc{HAS_AntiTNF_2019,
  author       = {{Haute Autorité de Santé}},
  title        = {Fiche de bon usage des médicaments: Anti-TNF alpha dans les maladies inflammatoires chroniques de l’intestin},
  year         = {2019},
  howpublished = {Recommandations officielles HAS},
  url          = {https://www.has-sante.fr/jcms/c_2859577/fr/anti-tnf-alpha-mici},
  note         = {Consulté en 2025}
}

@misc{UEG2022DigestiveHealth,
  author       = {{United European Gastroenterology}},
  title        = {Digestive Health Across Europe 2022: A report for policymakers, researchers and clinicians},
  howpublished = {\url{https://ueg.eu/files/757/e8d111da646cb94d045dea61fd9f3f0f.pdf}},
  year         = {2022},
  note         = {UEG J},
}
@article{Peeraphatdit_ImmuneHepatitis_2020,
  title={Liver injury from immune checkpoint inhibitors},
  author={Peeraphatdit, Thitis and al.},
  journal={Hepatology},
  year={2020},
  volume={72},
  pages={1164-1175}
}

@article{DeMartin_IOHepatitis_2020,
  title={Diagnosis and management of immune-related hepatitis in cancer patients treated with immune checkpoint inhibitors},
  author={De Martin, Elisabetta and al.},
  journal={Journal of Hepatology},
  year={2020},
  volume={72},
  pages={458-466}
}

@article{Friedman_FibrosisRegression_2023,
  title={Fibrosis regression and implications for clinical trials in NASH},
  author={Friedman, Scott and al.},
  journal={Nature Reviews Gastroenterology \& Hepatology},
  year={2023},
  volume={20},
  pages={89-104}
}
@article{Guerin2013AlcoolMortalite,
  author    = {Gu{\'e}rin, S. and Laplanche, A. and Dunant, A. and Hill, C.},
  title     = {Alcohol-attributable mortality in France},
  shorttitle= {Alcohol mortality France},
  journal   = {Eur J Public Health},
  year      = {2013},
  volume    = {23},
  number    = {4},
  pages     = {588--593}
}

@report{Kopp2015CoutSocial,
  author       = {Kopp, Pierre},
  title        = {Le co{\^u}t social des drogues en France},
  shorttitle   = {Co{\^u}t social drogues},
  institution  = {OFDT},
  year         = {2015},
  address      = {Paris},
  url          = {https://www.ofdt.fr/BDD/publications/docs/epfxpk6b.pdf}
}

@article{Schwarzinger2018AlcoholDementia,
  author    = {Schwarzinger, Micha{\"e}l and Pollock, Bruce G. and Hasan, Omar S. M. and et al.},
  title     = {Alcohol use disorders and dementia: a nationwide cohort study},
  shorttitle= {Alcohol and dementia},
  journal   = {Lancet Public Health},
  year      = {2018},
  volume    = {3},
  number    = {3},
  pages     = {e124--e132},
  doi       = {10.1016/S2468-2667(18)30022-7}
}

@article{Richard2019AlcoolSPF,
  author    = {Richard, Jean-Baptiste and Andler, Roxane and Guignard, Romain and Beck, Fran{\c c}ois and Arwidson, Pierre},
  title     = {La consommation d’alcool en France en 2017 : r{\'e}sultats du Barom{\`e}tre de Sant{\'e} publique France},
  shorttitle= {Alcool France 2017},
  journal   = {Bull Epidemiol Hebd},
  year      = {2019},
  number    = {16},
  pages     = {299--308}
}

@report{SFA2014Reco,
  author       = {{Soci{\'e}t{\'e} Fran{\c c}aise d’Alcoologie}},
  title        = {Recommandations fran{\c c}aises sur les troubles de l’usage d’alcool},
  shorttitle   = {Recommandations SFA 2014},
  year         = {2014},
  institution  = {Soci{\'e}t{\'e} Fran{\c c}aise d’Alcoologie},
  address      = {Paris},
  url          = {https://www.sfalcoologie.asso.fr}
}

@article{Parlati2025RehabAH,
  author    = {Parlati, Lucia and Mouliade, Charlotte and Nguyen Khac, Eric and Collier, Mathis and Tzedakis, Stylianos and Bouam, Samir and Courtois, Anoisia and Corouge, Marion and Louvet, Alexandre and Pol, Stanislas and Sogni, Philippe and Benyamina, Amine and Rehm, J{\"u}rgen and Mathurin, Philippe and Mallet, Vincent},
  title     = {Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National Analysis},
  shorttitle= {Rehab after alcohol hepatitis},
  journal   = {Clin Gastroenterol Hepatol},
  year      = {2025},
  volume    = {23},
  number    = {5},
  pages     = {808--815.e5},
  doi       = {10.1016/j.cgh.2024.07.037}
}

@article{Schwarzinger2017ChronicDisease,
  author    = {Schwarzinger, Micha{\"e}l and Thi{\'e}baut, Sophie Pascale and Baillot, Sylvain and Mallet, Vincent and Rehm, J{\"u}rgen},
  title     = {Alcohol use disorders and associated chronic disease: a national retrospective cohort study from France},
  shorttitle= {AUDs and chronic disease},
  journal   = {BMC Public Health},
  year      = {2017},
  volume    = {18},
  number    = {1},
  pages     = {43},
  doi       = {10.1186/s12889-017-4587-y}
}

@article{Mallet2022T2DLiverBurden,
  author    = {Mallet, Vincent and Parlati, Lucia and Martinino, Alessandro and Scarano Pereira, Juan Pablo and Jimenez, Carmen Navas and Sakka, Mehdi and Bouam, Samir and Retbi, Aur{\'e}lia and Krasteva, Donika and Meritet, Jean-Fran{\c c}ois and Schwarzinger, Michael and Thabut, Dominique and Rufat, Pierre and Bonnefont-Rousselot, Dominique and Sogni, Philippe and Pol, Stanislas and Tsochatzis, Emmanuel},
  title     = {Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus},
  shorttitle= {Liver burden in T2D},
  journal   = {J Hepatol},
  year      = {2022},
  volume    = {76},
  number    = {2},
  pages     = {265--274},
  doi       = {10.1016/j.jhep.2021.09.030}
}

@article{Schwarzinger2024RehabCancer,
  author    = {Schwarzinger, Micha{\"e}l and Ferreira-Borges, Carina and Neufeld, Maria and Alla, Fran{\c c}ois and Rehm, J{\"u}rgen},
  title     = {Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France},
  shorttitle= {Rehab and cancer risk},
  journal   = {Lancet Public Health},
  year      = {2024},
  volume    = {9},
  number    = {7},
  pages     = {e461--e469},
  doi       = {10.1016/S2468-2667(24)00107-5}
}

@article{Poynard1997AlcoholHCV,
  author    = {Poynard, Thierry and Bedossa, Pierre and Opolon, Pierre},
  title     = {Natural history of liver fibrosis progression in patients with chronic hepatitis C},
  shorttitle= {Fibrosis progression in HCV},
  journal   = {Lancet},
  year      = {1997},
  volume    = {349},
  number    = {9055},
  pages     = {825--832}
}

@article{Chang2019AlcoholNAFLD,
  author    = {Chang, Yoosoo and Cho, Yejin and Park, Hocheol and et al.},
  title     = {Moderate alcohol consumption is associated with increased fibrosis risk in non-alcoholic fatty liver disease},
  shorttitle= {Alcohol and MASLD fibrosis},
  journal   = {Hepatology},
  year      = {2019},
  volume    = {69},
  number    = {5},
  pages     = {1881--1893},
  doi       = {10.1002/hep.30455}
}

@article{Louvet2008AHA,
  author    = {Louvet, Alexandre and Naveau, Sylvie and Abdelnour, M. and et al.},
  title     = {The prognostic significance of alcoholic hepatitis according to the alcohol consumption after liver injury},
  shorttitle= {Prognosis alcoholic hepatitis},
  journal   = {Gastroenterology},
  year      = {2008},
  volume    = {135},
  number    = {6},
  pages     = {1781--1789},
  doi       = {10.1053/j.gastro.2008.08.054}
}

@article{RN597,
  author       = {{European Association for the Study of the Liver} and
                  {European Association for the Study of Diabetes} and
                  {European Association for the Study of Obesity}},
  title        = {EASL--EASD--EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)},
  journal      = {J Hepatol},
  shortjournal = {J Hepatol},
  year         = {2024},
  volume       = {81},
  number       = {3},
  pages        = {492--542},
  doi          = {10.1016/j.jhep.2024.04.031}
}

@article{RN565,
  author       = {Targher, Giovanni and Valenti, Luca and Byrne, Christopher D.},
  title        = {Metabolic Dysfunction--Associated Steatotic Liver Disease},
  journal      = {N Engl J Med},
  shortjournal = {N Engl J Med},
  year         = {2025},
  volume       = {393},
  number       = {7},
  pages        = {683--698},
  doi          = {10.1056/NEJMra2412865}
}

@article{Alcohol_CLD_Progression_Risk,
  author       = {Jophlin, L. L. and Singal, A. K. and Bataller, R. and Wong, R. J. and Sauer, B. G. and Terrault, N. A. and Shah, V. H.},
  title        = {ACG Clinical Guideline: Alcohol-Associated Liver Disease},
  journal      = {Am J Gastroenterol},
  year         = {2024},
  volume       = {119},
  number       = {1},
  pages        = {30--54},
  doi          = {10.14309/ajg.0000000000002572},
  issn         = {0002-9270},
  abstract     = {Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic disease and frequent indication for liver transplantation worldwide. With harmful alcohol use as the primary risk factor, increasing alcohol use over the past decade has resulted in rapid growth of the ALD-related healthcare burden. The spectrum of ALD ranges from early asymptomatic liver injury to advanced disease with decompensation and portal hypertension. Compared with those with other etiologies of liver disease, patients with ALD progress faster and more often present at an advanced stage. A unique phenotype of advanced disease is alcohol-associated hepatitis (AH) presenting with rapid onset or worsening of jaundice, and acute on chronic liver failure in severe forms conveying a 1-month mortality risk of 20\%--50\%. The Model for End-Stage Liver Disease score is the most accurate score to stratify AH severity (>20 defined as severe disease). Corticosteroids are currently the only available therapeutic with proven efficacy for patients with severe AH, providing survival benefit at 1 month in 50\%--60\% of patients. Abstinence of alcohol use, a crucial determinant of long-term outcomes, is challenging to achieve in ALD patients with concurrent alcohol use disorder. Strategies are needed to overcome barriers to treatment and to promote a multidisciplinary integrated care model.},
  keywords     = {Liver Diseases, Alcoholic; Hepatitis, Alcoholic; Alcoholism; Liver Cirrhosis},
}

@article{Chen2017,
  author  = {Chen, C.K. and Boos, J. and Sarwar, A. and O'Bryan-Alberts, B. and Ahmed, M. and Brook, O.R.},
  title   = {Observation time after outpatient non-arterial interventional procedures: standards, safety, and outcomes},
  journal = {Abdom Radiol (NY)},
  year    = {2017},
  volume  = {42},
  number  = {5},
  pages   = {1571--1578},
  doi     = {10.1007/s00261-017-1046-2},
  url     = {https://doi.org/10.1007/s00261-017-1046-2}
}

@article{cirse2021,
  author  = {Mahnken, A.H. and de Baère, T. and Gangi, A.},
  title   = {CIRSE Clinical Practice Manual on percutaneous needle biopsy and other interventional procedures},
  journal = {Cardiovasc Intervent Radiol},
  year    = {2021},
  volume  = {44},
  number  = {4},
  pages   = {543--555},
  doi     = {10.1007/s00270-020-02904-3},
  url     = {https://doi.org/10.1007/s00270-020-02904-3}
}

@article{cirse2017,
  author  = {Veltri, A. and Bargellini, I. and Giorgi, L. and Almeida, P.A.M.S. and Akhan, O.},
  title   = {CIRSE Guidelines on Percutaneous Needle Biopsy (PNB)},
  journal = {Cardiovasc Intervent Radiol},
  year    = {2017},
  volume  = {40},
  number  = {10},
  pages   = {1501--1513},
  doi     = {10.1007/s00270-017-1658-5},
  url     = {https://doi.org/10.1007/s00270-017-1658-5}
}

@article{Lakshminarayan2023,
  author  = {Lakshminarayan, R. and Bent, C. and Taylor, J. and Bryant, T. and Ahmad, R. and Diamantopoulos, A. and Morgan, R.A.},
  title   = {Developing day-case units: imperative for optimal patient care in interventional radiology},
  journal = {Clin Radiol},
  year    = {2023},
  volume  = {78},
  number  = {4},
  pages   = {295--300},
  doi     = {10.1016/j.crad.2022.11.017},
  url     = {https://doi.org/10.1016/j.crad.2022.11.017}
}

@article{RN50,
  author  = {Chen, C. K. and Boos, J. and Sarwar, A. and O'Bryan-Alberts, B. and Ahmed, M. and Brook, O. R.},
  title   = {Observation time after outpatient non-arterial interventional procedures: standards, safety, and outcomes},
  journal = {Abdominal Radiology},
  volume  = {42},
  number  = {5},
  pages   = {1571--1578},
  year    = {2017},
  doi     = {10.1007/s00261-017-1046-2},
  url     = {https://link.springer.com/article/10.1007/s00261-017-1046-2}
}
@article{RN51,
  author  = {Veltri, A. and Bargellini, I. and Giorgi, L. and Almeida, P. A. M. S. and Akhan, O.},
  title   = {CIRSE Guidelines on Percutaneous Needle Biopsy (PNB)},
  journal = {Cardiovascular and Interventional Radiology},
  volume  = {40},
  number  = {10},
  pages   = {1501--1513},
  year    = {2017},
  doi     = {10.1007/s00270-017-1658-5},
  url     = {https://link.springer.com/article/10.1007/s00270-017-1658-5}
}
@article{RN52,
  author  = {Mahnken, A. H. and de Baère, T. and Gangi, A.},
  title   = {CIRSE Clinical Practice Manual on percutaneous needle biopsy and other interventional procedures},
  journal = {Cardiovascular and Interventional Radiology},
  volume  = {44},
  number  = {4},
  pages   = {543--555},
  year    = {2021},
  doi     = {10.1007/s00270-020-02904-3},
  url     = {https://link.springer.com/article/10.1007/s00270-020-02904-3}
}
@article{Prince2019,
  author  = {Prince, R. M. and Powis, M. and Zer, A. and Atenafu, E. G. and Krzyzanowska, M. K.},
  title   = {Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis},
  journal = {European Journal of Cancer Care},
  volume  = {28},
  number  = {1},
  pages   = {e12909},
  year    = {2019},
  doi     = {10.1111/ecc.12909},
  url     = {https://onlinelibrary.wiley.com/doi/10.1111/ecc.12909}
}
@misc{APHP2020,
  title     = {Chimiothérapies injectables --- Référentiel organisationnel pour sécurité et qualité des soins en hôpital de jour},
  publisher = {Assistance Publique--Hôpitaux de Paris},
  year      = {2020},
  url       = {https://cme.aphp.fr/sites/default/files/CMEDoc/qsscapcu28octobre2020_chimiotherapiesinjectables.pdf},
  note      = {Consulté le 03/12/2025}
}
@misc{ONC2021,
  title     = {Sécurisation médicamenteuse des patients traités par anticancéreux injectables en hôpital de jour d’oncologie-hématologie --- Référentiel organisationnel},
  publisher = {Fédération Nationale des Centres de Lutte Contre le Cancer},
  year      = {2021},
  url       = {https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-referentiel-organisatio},
  note      = {Consulté le 03/12/2025}
}
@misc{INCa2025_SECUMED,
  title     = {Sécurisation médicamenteuse des patients traités par anticancéreux injectables en hôpital de jour d’oncologie-hématologie – Référentiel organisationnel},
  author    = {{Institut National du Cancer}},
  year      = {2025},
  month     = feb,
  note      = {Réf. REFSECUMED25},
  url       = {https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-referentiel-organisatio}
}
